Jennifer L. Good
Net Worth

Last updated:

What is Jennifer L. Good net worth?

The estimated net worth of Ms. Jennifer L. Good is at least $5,812,837 as of 9 Sep 2024. She owns shares worth $1,563,584 as insider, has earned $273,413 from insider trading and has received compensation worth at least $3,975,840 in Trevi Therapeutics, Inc..

What is the salary of Jennifer L. Good?

Ms. Jennifer L. Good salary is $662,640 per year as Co-Founder, Chief Executive Officer, Pres & Director in Trevi Therapeutics, Inc..

How old is Jennifer L. Good?

Ms. Jennifer L. Good is 60 years old, born in 1965.

What stocks does Jennifer L. Good currently own?

As insider, Ms. Jennifer L. Good owns shares in one company:

Company Title Shares Price per share Total value
Trevi Therapeutics, Inc. (TRVI) Co-Founder, Chief Executive Officer, Pres & Director 213,313 $7.33 $1,563,584

What does Trevi Therapeutics, Inc. do?

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

TRVI logo
TRVI
Trevi Therapeutics, Inc.
$7.33

Jennifer L. Good insider trading

Trevi Therapeutics, Inc.

Ms. Jennifer L. Good has made 7 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 40,277 units of TRVI stock on 5 Sep 2024. As of 9 Sep 2024 she still owns at least 213,313 units of TRVI stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (right to buy) 1,840 $1.43 $2,631
Option
Common Stock 1,840 $1.43 $2,631
Sale
Common Stock 1,840 $3.04 $5,586
Option
Stock Option (right to buy) 4,219 $1.43 $6,033
Sale
Common Stock 4,219 $3.03 $12,784
Option
Common Stock 4,219 $1.43 $6,033
Sale
Common Stock 40,277 $3.11 $125,302
Option
Stock Option (right to buy) 40,277 $1.43 $57,596
Option
Common Stock 40,277 $1.43 $57,596
Option
Common Stock 10,981 $1.43 $15,703
Option
Stock Option (right to buy) 10,981 $1.43 $15,703
Sale
Common Stock 10,981 $3.02 $33,207
Sale
Common Stock 3,863 $3.02 $11,678
Option
Stock Option (right to buy) 3,863 $1.43 $5,524
Option
Common Stock 3,863 $1.43 $5,524
Option
Common Stock 25,037 $2.19 $54,831
Option
Stock Option (right to buy) 25,037 $2.19 $54,831
Sale
Common Stock 25,037 $2.86 $71,581
Sale
Common Stock 4,578 $2.9 $13,276
Option
Common Stock 4,578 $2.19 $10,026
Option
Stock Option (right to buy) 4,578 $2.19 $10,026
Purchase
Common Stock 11,250 N/A N/A

Trevi Therapeutics key executives

Trevi Therapeutics, Inc. executives and other stock owners filed with the SEC: